Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 3,305.00
+30.00 (0.92%)
Last updated: Jun 24, 2026, 1:44 PM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 66.69 billion as of June 24, 2026. Its market cap has decreased by -31.84% in one year.
Market Cap
66.69B
Enterprise Value
88.24B
Revenue
177.97B
Ranking
n/a
PE Ratio
11.25
Stock Price
3,305.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 66.69B, an increase of 124.98%. That is a compound annual growth rate of 4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 66.69B | -23.84% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilsung Is | 134.78B |
| SAMSUNG PHARM. Co., LTD. | 127.63B |
| AptaBio Therapeutics | 126.98B |
| Kyongbo Pharmaceutical | 120.73B |
| Jeil Pharma Holdings | 108.69B |
| HANDOK | 99.64B |
| CKD Bio | 79.55B |
| Enzychem Lifesciences | 76.86B |